Litigation Intel

NEC Preterm Infant Formula

Parents of premature infants who developed necrotizing enterocolitis after cow milk based formula such as Similac or Enfamil are pursuing claims against Abbott and Mead Johnson.

Composite score
81
Scored Oct 26, 8:01 AM

NEC litigation shows sustained high activity driven by significant trial verdicts, supportive clinical literature, and persistent nationwide plaintiff intake marketing.

Score breakdown

Four dimensions, each 0-100, generated by AI from the recent signal feed plus general knowledge of the tort.

Momentum82

Substantial state court trial verdicts and ongoing MDL proceedings maintain high activity levels across federal and state dockets.

Science88

Extensive peer reviewed literature and recent meta analyses consistently associate bovine based formulas with elevated necrotizing enterocolitis risk in preterm infants.

Campaign84

Plaintiff law firms continue running widespread intake operations and multi channel advertising targeting parents of premature infants affected by infant formula.

Litigation stage68

Multiple state bellwether trials have reached verdicts, while federal MDL bellwether preparations continue to move the litigation through middle procedural stages.

Scores are generated by AI from public sources for market research. They are not legal advice or a prediction of any outcome.

Buying cases in this litigation?

We can launch an exclusive campaign to your intake criteria within one week.

Signal feed

10 recent signals across news, FDA, PubMed, and court sources.